Melinta是Cempra制药公司的继承实体。Cempra制药公司位于北卡罗来纳州教堂山市,于2005年11月18日成立,是一家开发抗细菌...查看全文
用户48783635432019-04-10 11:18
【4月9日医药股盘点】$Histogenics(HSGX)$$PhaseBio制药(PHAS)$ $Melinta Therapeutics(MLNT)$ 细胞疗法公司Histogenics同制药公司Ocugen合并,上涨56%;制药公司PhaseBio Pharmaceuticals上涨17.15%;抗生素开发公司Melinta Therapeutics上涨15.15%等。查看全文网页链接查看全文
$Melinta Therapeutics, Inc.(MLNT)$ CT ORDER - Confidential treatment order Filed: 2018-06-11 AccNo: 9999999997-18-006333 Size: 11 KB 网页链接
$Melinta Therapeutics, Inc.(MLNT)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2018-06-11 AccNo: 0000315066-18-001967 Size: 9 KB 网页链接
$Melinta Therapeutics, Inc.(MLNT)$ 8-K/A [Amend] - Current report Filed: 2018-06-08 AccNo: 0001193125-18-188165 Size: 544 KBItem 9.01: Financial Statements and Exhibits 网页链接
$Melinta Therapeutics, Inc.(MLNT)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2018-05-31 AccNo: 0001193125-18-180487 Size: 80 KB 网页链接
$Melinta Therapeutics, Inc.(MLNT)$ 8-K - Current report Filed: 2018-05-29 AccNo: 0001193125-18-176956 Size: 271 KBItem 1.01: Entry into a Material Definitive AgreementItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Melinta Therapeutics, Inc.(MLNT)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2018-05-25 AccNo: 0001193125-18-174174 Size: 495 KB 网页链接
$Melinta Therapeutics, Inc.(MLNT)$ FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses Filed: 2018-05-21 AccNo: 0001193125-18-169535 Size: 22 KB 网页链接
$Melinta Therapeutics, Inc.(MLNT)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2018-05-21 AccNo: 0001193125-18-169508 Size: 497 KB 网页链接
$Melinta Therapeutics, Inc.(MLNT)$ DEF 14A - Other definitive proxy statements Filed: 2018-05-11 AccNo: 0001564590-18-013242 Size: 3 MB 网页链接
$Melinta Therapeutics, Inc.(MLNT)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-05-10 AccNo: 0001564590-18-013043 Size: 8 MB 网页链接